These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35169512)

  • 41. Valproate in Pregnancy: Recent Research and Regulatory Responses.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VALPROATE, BIPOLAR DISORDER AND POLYCYSTIC OVARIAN SYNDROME.
    Okanović M; Zivanović O
    Med Pregl; 2016; 69(3-4):121-6. PubMed ID: 27506102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
    Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
    Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
    JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing epilepsy in women of childbearing age.
    Crawford PM
    Drug Saf; 2009; 32(4):293-307. PubMed ID: 19388721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary.
    Patel N; Viguera AC; Baldessarini RJ
    J Clin Psychopharmacol; 2018 Feb; 38(1):7-10. PubMed ID: 29215383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate.
    Turner S; Sucheston ME; De Philip RM; Paulson RB
    Teratology; 1990 Apr; 41(4):421-42. PubMed ID: 2111044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
    Chengappa KN; Chalasani L; Brar JS; Parepally H; Houck P; Levine J
    Clin Ther; 2002 Oct; 24(10):1576-84. PubMed ID: 12462287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of bipolar disorder during pregnancy and the postpartum period.
    Yonkers KA; Wisner KL; Stowe Z; Leibenluft E; Cohen L; Miller L; Manber R; Viguera A; Suppes T; Altshuler L
    Am J Psychiatry; 2004 Apr; 161(4):608-20. PubMed ID: 15056503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Valproate prescription prevalence among women of childbearing age.
    Wisner KL; Leckman-Westin E; Finnerty M; Essock SM
    Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valproate-associated reproductive hormone abnormalities: do bipolar men have the same risk as epileptic men?
    Aldemir E; Akdeniz F; Altay AB; Arıcı Ş; Umul M; Aydın HH; Çelebisoy M; Vahip S
    Turk Psikiyatri Derg; 2012; 23(4):223-7. PubMed ID: 23225122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk management of teratogenic medicines: A systematic review.
    Shroukh WA; Steinke DT; Willis SC
    Birth Defects Res; 2020 Dec; 112(20):1755-1786. PubMed ID: 32918401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-world prescribing trends of valproate in women with epilepsy in Korea.
    Han SH; Lee H; Shin JY; Moon HJ; Lee SY
    Epilepsy Behav; 2021 Feb; 115():107700. PubMed ID: 33421853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
    O'Donovan C; Kusumakar V; Graves GR; Bird DC
    J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caring for women with childbearing potential taking teratogenic dermatologic drugs. Guidelines for practice.
    Perlman SE; Rudy SJ; Pinto C; Townsend-Akpan C
    J Reprod Med; 2001 Feb; 46(2 Suppl):153-61. PubMed ID: 11255823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
    Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
    Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.
    Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC; Silverstone PH
    Ann Gen Hosp Psychiatry; 2004 Jul; 3(1):13. PubMed ID: 15283867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
    Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
    Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.